… in patients hospitalized with Covid-19, we randomly assigned 1561 patients to receive
hydroxychloroquine and 3155 to receive usual care. The primary outcome was 28-day mortality. …

… The antiviral action of hydroxychloroquine and chloroquine has … conducted on 2019 novel
coronavirus (covid-19). The purpose of … use they can have on the current covid-19 pandemic. …

… Race and ethnicity were reported in this study because the efficacy of hydroxychloroquine
for COVID-19 might vary by race or ethnicity. Race and ethnicity were reported by the …

… We propose that the anti-inflammatory and immunomodulatory effects of CQ and HCQ are
the mechanisms of therapeutic effects that may be seen in COVID-19 patients at the severe …

… adverse effects when combined with certain other drugs. Here we will review the known effects
… evidence to date and notable considerations for HCQ therapy in patients with COVID‐19. …

… EUA) to use both the drugs in the treatment of COVID-19 on March 30, 2020. Historically, this
… on COVID-19 have recently become available, we aimed to study its effect on COVID-19 on …

… , severe acute respiratory syndrome coronavirus 2 (SARS-CoV-… emergently began trialing
hydroxychloroquine (HCQ) in efforts … to assess the effects of HCQ on patients with COVID-19. …

… To assess the safety and effects of CQ in patients with COVID-19, we registered this trial
in ChiCTR and chose HCQ (the sulfate and phosphate salts of CQ) as the intervention agent. …

… the use of hydroxychloroquine in patients with COVID-19 … hydroxychloroquine does not
appear to lead to a more rapid negative conversion by RT-PCR. Exposure to hydroxychloroquine …

… effects outweigh its protective effect from radiological progression in nonsevere COVID-19
patients… Benefit-risk balance should determine the hydroxychloroquine use in COVID-19. …